Digest Network Come funziona
Network
/
Società
Na
Non verificato

Natera, Inc.

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

147 comunicati stampa

Guarda tutti i comunicati
27/10/2026
Biotecnologia
Medicina - Varie
Salute
Vetrine/Shopping
Farmaceutica
Oncologia
Eventi
Industria
Signatera™ Genome with Phased and Structural Variants Highlighted in ESMO Presidential Symposium, Supporting the Critical Role of MRD-Guided Treatment in Bladder Cancer
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
26/10/2026
Scienza
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Eventi
Fiere
Industria
Natera Shares Real-World Analyses and Data at ASN Kidney Week 2026, Highlighting the Critical Need for Genetic Testing with Renasight™
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
18/10/2026
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Oncologia
Fiere
Eventi
ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
15/10/2026
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
Eventi
Natera’s Signatera™ MRD Test Named to TIME’s List of the Best Inventions of 2026
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
13/10/2026
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
Mercato del lavoro
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
09/10/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Oncologia
FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
07/10/2026
Industria
Scienza
Sanità
Farmaceutica
Oncologia
Vetrine/Shopping
Biotecnologia
Medicina - Varie
Biologia
Salute
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
06/10/2026
Eventi
Fiere
Industria
Scienza
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Medicina nucleare
Salute
Oncologia
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
05/10/2026
Multimedialità
Mercato del lavoro
Industria
Scienza
Sanità
Farmaceutica
Oncologia
Vetrine/Shopping
Biotecnologia
Medicina - Varie
Salute
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0
22/09/2026
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Sanità
Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
Fonte
Natera, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0